Resolution of Sickle Cell Leg Ulcers with Voxelotor (RESOLVE)
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients With Sickle Cell Disease
Category & Conditions: Rare Diseases
Medicine: OXBRYTA(VOXELOTOR)
ClinicalTrials.gov Identifier (NCT): NCT05561140
Protocol ID: C5341026 (GBT440-042)
Open Plain Language Summary Result:
Click here